Practical experiments illustrated that PCED1B-AS1's gene silencing repressed the proliferation of glioma cells and induced apoptosis, indicating that PCED1B-AS1 provided an auspicious biomarker for the prognosis, as well as drug targets of glioma [58, 59]. The gene discussed is PCED1B; the disease is glioma.